Detail
LncRNA Name | RERT |
Synonyms | NA |
Region | GRCh38_19:40778242-40808418 Sequence |
Ensembl | ENSG00000171570 |
RefSeq | NA |
Circulating | ✔ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | hepatocellular carcinoma |
ICD-0-3 | C22.0 M8170/3 |
Methods | qPCR, Western blot etc. |
Sample | HCC tissues, cell lines (HepG2, Hep3B, sk-Hep-1, SMMC-7721 etc.) |
Expression Pattern | up-regulated |
Function Description | The contribution of rs10680577 to HCC risk was investigated in 623 HCC cases and 1,242 controls and replicated in an independent case-control study consisting of 444 HCC cases and 450 controls. Logistic regression analysis showed that the deletion allele of rs10680577 was significantly associated with increased risk for HCC occurrence in both case-control studies. Genotype-phenotype correlation studies showed that the deletion allele was significantly correlated with higher expression of both EGLN2 and RERT-lncRNA in vivo and in vitro. Furthermore, RERT-lncRNA expression was also significantly correlated with EGLN2 expression in vivo, consistent with in vitro gain-of-function study that showed overexpressing RERT-lncRNA upregulated EGLN2. Finally, in silico prediction suggested that the insertion allele could disrupt the structure of RERT-lncRNA. |
Pubmed ID | 23026137 |
Year | 2012 |
Title | An insertion/deletion polymorphism within RERT-lncRNA modulates hepatocellular carcinoma risk. |
External Links |
Links for RERT | GenBank HGNC lncrnadb Noncode |
Links for hepatocellular carcinoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.